tempting to define the new technology and its interoperability associated with clinical research. Newtown-based global clinical trial solutions provider BioClinica, which re-branded itself two years ago with a focus on its eClinical services, has since had little trouble defining the term or how its driving the companys growth.
What weve found is eClinical has a very broad definition, says BioClinica CEO Mark Weinstein. Whats happened is you have these silo systems that have been developed in pharma and are very rich in vertical niches they serve but nobody was developing truly integrated solutions, which is ultimately the next phase.
In September, BioClinica acquired Tourtellette Solutions of Massachusetts, which created the first major parameter-driven interactive voice response (IVR) and the worlds first interactive web response (IWR) for a top-five global pharma company. The technologies allow a computer t
o detect voice or keypad inputs (IVR) or gather patient data through a web-based system (IWR) and is used extensively in clinical trials to gather and maintain patient testing results. Tourtellette is building a new, configurable IVR product that BioClinica expects to unveil in June.
BioClinica, Weinstein says, generated more than $70 million in revenues last year and expects that figure to grow in 2010. Last week, it opened a new, 36,000 square foot office in Audobon, Montgomery County that will house much of its eClinical efforts. It also hired industry veteran Robert Sammis as VP of finance for its eClinical division. Hell oversee finance and human resources within the unit.
Im a huge believer that we have to continue to build our bench strength, says Weinstein. Robert was an amazing find. He has a tremendous amount of pharma experience and it happens that hes a CPA as well.
Source: Mark Weinstein, BioClinica
Writer: Joe Petrucci
Photos: Top, Mark Weinstein; Bottom, Robert Sammis.